These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 17981637)

  • 1. Nucleic acid-based inhibition of flavivirus infections.
    Stein DA; Shi PY
    Front Biosci; 2008 Jan; 13():1385-95. PubMed ID: 17981637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noncoding Subgenomic Flavivirus RNA Is Processed by the Mosquito RNA Interference Machinery and Determines West Nile Virus Transmission by Culex pipiens Mosquitoes.
    Göertz GP; Fros JJ; Miesen P; Vogels CBF; van der Bent ML; Geertsema C; Koenraadt CJM; van Rij RP; van Oers MM; Pijlman GP
    J Virol; 2016 Nov; 90(22):10145-10159. PubMed ID: 27581979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available.
    Ishikawa T; Yamanaka A; Konishi E
    Vaccine; 2014 Mar; 32(12):1326-37. PubMed ID: 24486372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dengue and other emerging flaviviruses.
    Solomon T; Mallewa M
    J Infect; 2001 Feb; 42(2):104-15. PubMed ID: 11531316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.
    Guy B; Guirakhoo F; Barban V; Higgs S; Monath TP; Lang J
    Vaccine; 2010 Jan; 28(3):632-49. PubMed ID: 19808029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses.
    Mackenzie JS; Gubler DJ; Petersen LR
    Nat Med; 2004 Dec; 10(12 Suppl):S98-109. PubMed ID: 15577938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis.
    Lai CJ; Monath TP
    Adv Virus Res; 2003; 61():469-509. PubMed ID: 14714441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The extent of homologous recombination in members of the genus Flavivirus.
    Twiddy SS; Holmes EC
    J Gen Virol; 2003 Feb; 84(Pt 2):429-440. PubMed ID: 12560576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current approaches in antiviral drug discovery against the Flaviviridae family.
    Baharuddin A; Hassan AA; Sheng GC; Nasir SB; Othman S; Yusof R; Othman R; Rahman NA
    Curr Pharm Des; 2014; 20(21):3428-44. PubMed ID: 24001228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in flavivirus antiviral drug discovery and vaccine development.
    Ray D; Shi PY
    Recent Pat Antiinfect Drug Discov; 2006 Jan; 1(1):45-55. PubMed ID: 18221133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse and hamster models for the study of therapy against flavivirus infections.
    Charlier N; De Clercq E; Neyts J
    Novartis Found Symp; 2006; 277():218-29; discussion 229-32, 251-3. PubMed ID: 17319165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipids and flaviviruses, present and future perspectives for the control of dengue, Zika, and West Nile viruses.
    Martín-Acebes MA; Vázquez-Calvo Á; Saiz JC
    Prog Lipid Res; 2016 Oct; 64():123-137. PubMed ID: 27702593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mechanism to explain protein abnormalities in schizophrenia based on the flavivirus resistance gene.
    Brown JS
    Mol Psychiatry; 2001 Nov; 6(6):701-11. PubMed ID: 11673799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flaviviruses and flavivirus vaccines.
    Heinz FX; Stiasny K
    Vaccine; 2012 Jun; 30(29):4301-6. PubMed ID: 22682286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prospects for treating mosquito-borne flavivirus encephalitides].
    Platonov AE; Karan' LS; Vengerov IuIa; Galimzianov KhM
    Ter Arkh; 2009; 81(11):68-73. PubMed ID: 20141019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid identification of vector-borne flaviviruses by mass spectrometry.
    Grant-Klein RJ; Baldwin CD; Turell MJ; Rossi CA; Li F; Lovari R; Crowder CD; Matthews HE; Rounds MA; Eshoo MW; Blyn LB; Ecker DJ; Sampath R; Whitehouse CA
    Mol Cell Probes; 2010 Aug; 24(4):219-28. PubMed ID: 20412852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional non-coding RNAs derived from the flavivirus 3' untranslated region.
    Clarke BD; Roby JA; Slonchak A; Khromykh AA
    Virus Res; 2015 Aug; 206():53-61. PubMed ID: 25660582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal Vaccination: A Promising Alternative Against Flaviviruses.
    Luria-Pérez R; Sánchez-Vargas LA; Muñoz-López P; Mellado-Sánchez G
    Front Cell Infect Microbiol; 2022; 12():887729. PubMed ID: 35782117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying optimal capsid duplication length for the stability of reporter flaviviruses.
    Baker C; Liu Y; Zou J; Muruato A; Xie X; Shi PY
    Emerg Microbes Infect; 2020 Dec; 9(1):2256-2265. PubMed ID: 32981479
    [No Abstract]   [Full Text] [Related]  

  • 20. Flavivirus NS1 Triggers Tissue-Specific Vascular Endothelial Dysfunction Reflecting Disease Tropism.
    Puerta-Guardo H; Glasner DR; Espinosa DA; Biering SB; Patana M; Ratnasiri K; Wang C; Beatty PR; Harris E
    Cell Rep; 2019 Feb; 26(6):1598-1613.e8. PubMed ID: 30726741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.